Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cucurbitacin I Inhibits Stat3 and Induces Apoptosis in Sézary Cells
Marloes S. van Kester, Jacoba J. Out‐Luiting, Peter A. von dem Borne, et al.
Journal of Investigative Dermatology (2008) Vol. 128, Iss. 7, pp. 1691-1695
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
Bharat B. Aggarwal, Ajaikumar B. Kunnumakkara, Kuzhuvelil B. Harikumar, et al.
Annals of the New York Academy of Sciences (2009) Vol. 1171, Iss. 1, pp. 59-76
Open Access | Times Cited: 625
Cancer Immunotherapy by Dendritic Cells
Cornelis J.M. Melief
Immunity (2008) Vol. 29, Iss. 3, pp. 372-383
Open Access | Times Cited: 504
Targeting STAT3 in cancer: how successful are we?
Peibin Yue, James Turkson
Expert Opinion on Investigational Drugs (2008) Vol. 18, Iss. 1, pp. 45-56
Open Access | Times Cited: 403
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
Sankhadip Bose, Sabyasachi Banerjee, Arijit Mondal, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1451-1451
Open Access | Times Cited: 158
Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment
Der‐Horng Lee, Gabriela B. Iwanski, Nils H. Thoennissen
The Scientific World JOURNAL (2010) Vol. 10, pp. 413-418
Open Access | Times Cited: 152
Biological activities and potential molecular targets of cucurbitacins
Xiuping Chen, Jiaolin Bao, Jiajie Guo, et al.
Anti-Cancer Drugs (2012) Vol. 23, Iss. 8, pp. 777-787
Closed Access | Times Cited: 143
Janus kinase inhibitors in dermatology: A systematic review
Rony Shreberk‐Hassidim, Yuval Ramot, Abraham Zlotogorski
Journal of the American Academy of Dermatology (2017) Vol. 76, Iss. 4, pp. 745-753.e19
Closed Access | Times Cited: 140
Cucurbitacins : A Promising Target for Cancer Therapy
Abdullah Alghasham
International Journal of Health Sciences (2013) Vol. 7, Iss. 1, pp. 77-89
Open Access | Times Cited: 132
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
Elena Netchiporouk, Ivan V. Litvinov, Linda Moreau, et al.
Cell Cycle (2014) Vol. 13, Iss. 21, pp. 3331-3335
Open Access | Times Cited: 118
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Blood (2016) Vol. 127, Iss. 10, pp. 1287-1296
Open Access | Times Cited: 99
MicroRNA-21 Expression in CD4+ T Cells Is Regulated by STAT3 and Is Pathologically Involved in Sézary Syndrome
Leslie van der Fits, Marloes S. van Kester, Yongjun Qin, et al.
Journal of Investigative Dermatology (2010) Vol. 131, Iss. 3, pp. 762-768
Open Access | Times Cited: 120
STAT3 Regulation of Glioblastoma Pathogenesis
Núria de la Iglesia, Sidharth V. Puram, Azad Bonni
Current Molecular Medicine (2009) Vol. 9, Iss. 5, pp. 580-590
Open Access | Times Cited: 116
Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
W-L Zhao
Leukemia (2009) Vol. 24, Iss. 1, pp. 13-21
Closed Access | Times Cited: 97
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL‐10 expression in cutaneous T‐cell lymphoma cells
CE Tiffon, J E Adams, Leslie van der Fits, et al.
British Journal of Pharmacology (2010) Vol. 162, Iss. 7, pp. 1590-1602
Open Access | Times Cited: 92
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity
Yuee Cai, Xiefan Fang, Chengwei He, et al.
The American Journal of Chinese Medicine (2015) Vol. 43, Iss. 07, pp. 1331-1350
Closed Access | Times Cited: 84
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer
Niroshaathevi Arumuggam, Neil A. Bhowmick, H.P. Vasantha Rupasinghe
Phytotherapy Research (2015) Vol. 29, Iss. 6, pp. 805-817
Closed Access | Times Cited: 75
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, et al.
Cell Cycle (2014) Vol. 13, Iss. 18, pp. 2975-2982
Open Access | Times Cited: 70
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Kazuyasu Fujii
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 68
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Marie Brachet‐Botineau, Marion Polomski, Heidi A. Neubauer, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 240-240
Open Access | Times Cited: 64
Genetic and epigenetic insights into cutaneous T-cell lymphoma
Cornelis P. Tensen, Koen D. Quint, Maarten H. Vermeer
Blood (2021) Vol. 139, Iss. 1, pp. 15-33
Open Access | Times Cited: 42
Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B
Meixia Zhang, Hongliang Zhang, Chunyan Sun, et al.
Cancer Chemotherapy and Pharmacology (2008) Vol. 63, Iss. 4, pp. 635-642
Closed Access | Times Cited: 76
STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Antonio Lavecchia, Carmen Di Giovanni, Ettore Novellino
Current Medicinal Chemistry (2011) Vol. 18, Iss. 16, pp. 2359-2375
Closed Access | Times Cited: 68
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma
Alisha Kashyap, Julia Dai, Xiao Ni
Cancers (2025) Vol. 17, Iss. 4, pp. 568-568
Open Access
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Vivian Wai Yan Lui, Daisy Yau, Elaine Yue Ling Wong, et al.
Carcinogenesis (2009) Vol. 30, Iss. 12, pp. 2085-2094
Closed Access | Times Cited: 68
Page 1 - Next Page

Scroll to top